AME Ametek

Q3 2025 10-Q

Filed: Oct 30, 2025Period ending Sep 30, 2025

Health Care

Industrial Instruments For Measurement, Display, and ControlSEC EDGAR

Ametek (AME) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 30, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Management Discussion & Analysis

• Revenue $1,892.6M Q3 2025, up $184.0M or 10.8% YoY from $1,708.6M in Q3 2024
• Operating margin 25.8% Q3 2025 vs 26.1% Q3 2024; segment margin 27.3% vs 27.5% YoY, with 130bps acquisition dilution

+3 more insights

Risk Factors

• Section 'risk_factors' was empty or not found.

Quarterly Financial Summary
XBRL

Revenue

$1.9B

▲ +10.8% YoY▲ +6.4% QoQ

Net Income

$371M

▲ +9.2% YoY▲ +3.6% QoQ

Net Margin

19.6%

▼ -29bp YoY▼ -53bp QoQ

Source: XBRL data from Ametek Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Get deeper insights on Ametek

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.